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obtain yes/no answers at alpha = 0.05, whereas this formulation is almost useless to
the policy maker, who is more interested in the amount of improvement that can be
expected in different segments ofsociety and the translation ofthat into demographic
and economic terms. Third, the book is revealing to those who imagine that even the
best-designed studies really answer the original questions definitively. A controversial
suggestion made in one of the discussions is that the investigators in a clinical trial
should be prohibited from drawing the policy-related conclusions from their research!
Obviously, there are arguments against, as well as for, this position.
Immunizations still emerge as the prototype ofmedically based preventive medicine,
with frequently impressive cost-benefit data. Even here, however, these ratios are quite
different when a disease is rare than when it is common, so that these relationships tend
to change over time, and the ratios are much more favorable for some immunizations
than for others.
The essays I found most interesting and helpful were those on the economic aspects
of prevention by Bengt Jonsson, immunization programs by Jeffrey Koplan, screening
programs by T.W. Meade, multiple risk factor intervention programs by Ingvar
Hjermann, tobacco-related diseases by Richard Peto, and the role of controlled trials
by Goeffrey Rose. Depending on background, others might find some of the other
essays more profitable, but all are solid contributions.
The book is strongly recommended to anyone interested in the area of preventive
medicine, especially in its application to the chronic diseases.
JAMES F. JEKEL
Department ofEpidemiology and Public Health
Yale University School o Medicine
CLINICAL EPIDEMIOLOGY: THE ARCHITECTURE OF CLINICAL RESEARCH. By Alvan R.
Feinstein. Philadelphia, W.B. Saunders Company, 1985. 812 pp. $60.00.
Alvan Feinstein's Clinical Epidemiology: The Architecture ofClinical Research is
an intellectually stimulating textbook for medical students, practicing clinicians,
clinical researchers, and epidemiologists. The text is an excellent resource for those
who evaluate clinical research, and it also serves as a valuable introduction to the
epidemiologic methods and techniques used for conducting clinical investigations.
Epidemiologists will find the clinical perspective ofepidemiologic issues refreshing, yet
the book is not a substitute for a comprehensive epidemiology text.
Dr. Feinstein separates the book into seven parts that provide an overview ofclinical
research. The subjects discussed include: an overview of research architecture, an
outline ofstatistical strategies, additional principles ofcause-effect research, structure
science and statistics in cross-sectional research, non-cohort structures in cause-effect
research, evaluation of processes, and additional topics. These parts are reasonably
distinct intellectual units, but one of the strengths of the text is the continuity carried
from section to section. The author is extremely successful in demonstrating the
clinical relevance of the research strategies he presents, and it is this clinical
perspective that facilitates smooth and understandable transitions.
Perhaps the greatest strength of the book is that the author is not constrained by
traditional approaches to epidemiology in his intellectual quest for rigorous science.
With an almost brazen disregard for his epidemiologic heritage, Dr. FeinsteinBOOK REVIEWS
rediscovers epidemiologic principles as they apply to clinical medicine and research.
His approach is fresh and invigorating. Experienced readers may be surprised by novel
presentations of traditional epidemiologic concepts, but this approach usually lends
vitality to these subjects. New readers will find the work to be a clear presentation of
the fundamentals ofclinical epidemiology. Although he offers little substantivechange
from standard epidemiologictechniques, Dr. Feinstein is willing to abandon traditional
epidemiologic vocabulary in order to clarify research architecture. For example, the
author rejects the epidemiologic nomenclature of "ecologic studies," preferring to
introduce the concept as "heterodemic research." Since "heterodemic" better
describesquotients in which the numerator is not necessarily included in thedenomina-
tor, and the new term is much moreclearly understood than "ecologic," thechange is a
commendable one. Rather than attempt to salvage ambiguous terminology, the author
frequently renames old concepts, gambling that his neologisms will be more lucid and
descriptive than the abused standard vocabulary. Many times the gamble pays off.
The independent approach that Dr. Feinstein brings to the textbookdoes not always
serve to his advantage, however. Although the author argues that he is "much more
concerned with improving the science than with christening the improvements," his
efforts to elucidate vocabulary often encumber an already burdened scientific commu-
nication. His frequent neologisms can make it difficult to read a chapter or section in
isolation. Despite the conceptual independence of each section of the book, each part
builds on the vocabulary established earlier. Since the vocabulary is not standard, it
can be awkward to focus attention on individual portions ofthe book.
In addition, this separatist presentation of epidemiologic principles augments
difficulties in communication with the scientific community. For example, Dr.
Feinstein defines sensitivity and positive predictivevalue as "nosologic sensitivity" and
"diagnostic sensitivity," respectively. The standard terminology is adequate and
unambiguous, and it is so firmly entrenched in the literature that no one other than a
reader ofClinicalEpidemiology will understand the distinction between nosologic and
diagnostic sensitivity. Clearly this is an unnecessary change. Although the author does
attempt to point out departures from standard terminology, he walks a tightrope while
balancing traditional epidemiologic vocabulary with novel insight and neologisms;
sometimes he leans too far.
The majority ofthe textbook is characterized bycareful reasoning, solidscience, and
good writing. Indeed, two sections deservespecia' attention. "An Outline ofStatistical
Strategies" is a four-chapter summaryofstatistical techniques available to the clinical
investigator. The author emphasizes non-parametric statistics (in order to reflect a
clinical orientation) without sacrificing attention to the parametric statistics more
familiar to the domain of public health epidemiology. The presentation is clear and
uncomplicated, and it stresses the basic statistical principles behind clinical research.
"Additional Topics" includes an excellent discussion of the meaning of "normal," a
briefsummary ofotherepidemiologic fields, and anoutstanding review oframdomized
clinical trials. The author's treatment ofclinical trials provides an insightful overview
of clinical epidemiology with examples that clearly illustrate the strengths and
weaknesses ofclinical research.
Each chapter includes a brief synopsis and a set of exercises. The synopses are
uniformly well written, and the exercises are well conceived. The problems not only
evaluate mastery of certain quantitative techniques, but they also serve to reinforce a
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conceptual understanding ofthe material. Answers and references for further reading
are provided.
Clinical Epidemiology is an interesting presentation of a field that is generally not
described in clinically applicable terms; however, the author's discussion of several
epidemiologic methods and principles is incomplete. For example, limitations in the
use of the kappa coefficient as a method ofquantifying inter-observer agreement are
not adequately addressed. In addition, confounding receives too little attention
considering its importance in conducting and evaluating research. These shortcomings
are important but do not diminish the relevance of understanding epidemiologic
techniques in a clinical setting. Clinical investigators will find the text to be a valuable
supplemental resource for conducting research, while other readers will discover it to
be an insightful tool for evaluating clinical research.
The author achieves a rare balance with Clinical Epidemiology: The Architecture
of Clinical Research. Quantitative methods of analysis are complemented with
discussions of theoretical strategies of research, and the text is framed within a
well-developed historical context of public health and clinical epidemiology. Dr.
Feinstein has written a textbook of clinical epidemiology that is rarely traditional,
sometimes controversial, and always interesting.
STEPHEN B. GRUBER
Graduate Student
Department ofEpidemiology andPublic Health
Yale University School o Medicine
IMMUNITY TO CANCER. Edited by Arnold E. Reif and Malcolm S. Mitchell. Orlando,
FL, Academic Press, Inc., Publishers, 1985. 659 pp. $43.00.
Immunity to Cancer is a volume containing 45 papers and six brief reports,
presented at a conference of the same title, held in September 1984 at Williamsburg,
Virginia. Written by a representative group of leaders in this field, the papers are
organized under five headings: Identification and Characterization of Tumor Anti-
gens, Immune Responses to Tumor Antigens, Regulation of the Immune Response to
Tumor Cells, Immunotherapy and Biomodulators, and Immunoprophylaxis.
In the first section, "Tumor Antigen Characterization," an opening chapter by
editor Reif detailing requirements for success in immunotherapy is followed by a
discussion on the origin and nature of tumor antigens. Specific tumor antigens in
human melanoma, lymphoma, Simian virus 40 transformed cells, and leukemia are
discussed in the eight papers that follow, and the means of their characterization is
described.
"Immune Responses to Tumor Antigens" is the topic ofthe second section, with the
emphasis on effector mechanisms, including NK, macrophage, humoral, and T-cell
responses to challenge by tumor antigens. The regulation of these responses is the
subject of the third section, where cellular interaction and the role of lymphokines in
tumor rejection is reviewed.
The fascinating field of biological response modifiers (BRMs) is the subject of the
fourth section. Both reviews of current developments and original research are
presented, as thymosins, extracted tumor-specific transplantation antigens, and inter-
leukin 2 are discussed as possible inducers ofthe immune response against neoplasia.